Anna Protopapas, a director at Mersana Therapeutics Inc . (NASDAQ:MRSN), recently reported a sale of company stock, according to a filing with the Securities and Exchange Commission. On January 15, ...
Designed to provide broad exposure to the Mid Cap Value segment of the US equity market, the First Trust SMID Cap Rising Dividend Achievers ETF (SDVY) is a passively managed exchange traded fund ...